Shilpa Medicare said that ANVISA-Brazil successfully completed good manufacturing practice (GMP) inspection at its subsidiary, Shilpa Pharma Lifesciences’ Active Pharmaceutical Ingredient (API) manufacturing facility, Unit II situated in Karnataka.
| Subscribe To Our Free Newsletter |
